YOKOWO (6800) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The core business maintained revenue and operating income growth, but earnings declined at the final stage after including non-operating and extraordinary gains and losses, making the quality of the revenue growth a key issue in this earnings result. Revenue was ¥660.6B (+6.8% YoY), while operating income was ¥32.6B (+5.3% YoY). However, ordinary income was ¥36.2B (△2.5% YoY), and net income was limited to ¥23.7B (△7.6% YoY). Operating income growth was limited relative to the increase in revenue, and the operating margin declined by approximately 7bp from the same period of the previous year. The decrease in net income was primarily attributable to extraordinary losses of ¥10.4B, including ¥9.3B in business structure improvement expenses and ¥1.0B in impairment losses, exceeding extraordinary gains of ¥5.3B.

Factors Affecting Earnings

【Revenue】Revenue was ¥660.6B, up +6.8% YoY, representing an increase of ¥42.0B. By segment, CTC was the main growth driver, increasing +25.8% YoY, with its revenue mix expanding to approximately 22% of total revenue. Meanwhile, VCCS, the largest segment with an approximately 63% revenue mix, declined △0.7% YoY, while FC・MD also remained broadly flat at △0.9% YoY. By region, Japan increased +15.0% YoY, Europe and the Americas increased +4.9% YoY, and Asia increased +1.2% YoY, with domestic operations and Europe and the Americas supporting revenue growth.

【Profit and Loss】Operating income was ¥32.6B (+5.3% YoY). CTC led the company-wide result as its operating margin improved significantly from 8.4% to 14.2%, while margin declines at VCCS (5.0%→3.7%) and FC・MD (7.8%→3.2%) served as offsetting factors. Ordinary income declined △2.5% YoY even after reflecting non-operating income and expenses, including a foreign exchange gain of ¥2.3B, while net income declined △7.6% YoY due to the impact of extraordinary losses exceeding extraordinary gains by ¥5.1B, including ¥9.3B in business structure improvement expenses and ¥1.0B in impairment losses. In conclusion, the earnings structure was one of revenue and operating income growth at the operating level, but declining earnings from the ordinary income level onward, and can be characterized as having a strong tendency toward revenue growth but net income decline.

Segment Analysis

Segment profit at CTC was ¥20.5B (+113.2% YoY), accounting for approximately 63% of company-wide operating income of ¥32.6B and making it the largest contributor to profitability. VCCS generated ¥15.5B (△26.1% YoY), while FC・MD generated ¥2.7B (△58.8% YoY), with both segments reporting lower profits. The Incubation Center continued to report an operating loss of ¥6.3B, which widened from a loss of ¥6.2B in the same period of the previous year. Although VCCS is the largest segment, accounting for approximately 63% of the revenue mix, its operating margin has declined to 3.7%, making it the primary constraint on company-wide profitability. The widening gap between businesses—with CTC achieving higher profitability while VCCS and FC・MD experienced deteriorating profitability—is the quarter's most significant structural characteristic.

Key Financial Indicators

【Profitability】The operating margin was 4.9% and the net profit margin was 3.6%, both slightly lower than in the same period of the previous year. The gross margin was 19.4%, while cost of sales accounted for 80.6% of revenue, creating a structural constraint on margin improvement.【Cash Quality】Comprehensive income of ¥48.2B exceeded net income of ¥23.6B by ¥24.6B, but the difference was primarily attributable to foreign currency translation adjustments of ¥20.5B and valuation differences on securities of ¥4.7B, and does not indicate an improvement in recurring earnings power.【Investment Efficiency】ROE remained at 4.3%, indicating room to improve capital efficiency through both the net profit margin and total asset turnover.【Financial Soundness】The equity ratio was 66.5%, and cash and deposits were ¥174.4B, indicating a conservative financial foundation.

Cash Flow Analysis

Although detailed disclosure of the cash flow statement is not available, an analysis of fund movements based on changes in the balance sheet indicates that cash and deposits increased slightly to ¥174.4B from ¥171.2B at the end of the previous fiscal year, with on-hand liquidity broadly maintained. Current assets of ¥536.5B exceeded current liabilities of ¥242.0B by ¥294.5B, indicating ample working capital. Inventories increased to ¥90.5B from ¥77.9B in the previous year, suggesting that inventory accumulation accompanying revenue expansion may be placing some pressure on working capital. Interest-bearing debt totaled ¥57.9B on a combined short- and long-term basis, while cash and deposits of ¥174.4B exceeded this amount. The company therefore remained in a net cash position, maintaining financial stability while absorbing temporary expenses associated with business structure improvements.

Quality of Earnings

The quality of earnings for the current period can be viewed favorably because recurring business profit and temporary factors can be clearly distinguished. Operating income of ¥32.6B represents recurring profit generated by the core business, while extraordinary gains of ¥5.3B include a non-recurring gain on negative goodwill of ¥3.1B associated with the transfer of Kowa Corporation's network solutions business. Of the ¥10.4B in extraordinary losses, ¥9.3B consisted of business structure improvement expenses, which can also be regarded as temporary costs associated with a review of future earnings power. A foreign exchange gain of ¥2.3B was recorded in non-operating income, equivalent to approximately 7% of operating income of ¥32.6B, leaving the impact of foreign exchange fluctuations in ordinary income. The ¥24.6B gap between comprehensive income of ¥48.2B and net income of ¥23.6B was primarily attributable to foreign currency translation adjustments and valuation differences on securities; it should be noted that this difference does not represent profit generated directly from business activities during the current period.

Earnings Forecasts and Guidance

Progress against the full-year company forecast was 74.2% for revenue, 72.6% for operating income, 77.9% for ordinary income, and 78.7% for net income. Progress in revenue and operating income was around the standard 75% level for the cumulative Q3 period. To achieve the full-year forecast, revenue of ¥229.4B and operating income of ¥12.4B will be required in Q4. Compared with the cumulative Q3 operating margin of 4.9%, the Q4 operating margin implied by the full-year forecast is approximately 5.4%, requiring a modest improvement in profitability. While the progress rate for ordinary income is relatively high, the full-year ordinary income forecast assumes substantial growth of +18.4% YoY, making trends in non-operating income and expenses a key factor in achieving the forecast.

Shareholder Returns

The Q2 dividend was ¥25.00 per share, and the payout ratio based on net income attributable to owners of the parent was 25.3%. The forecast payout ratio calculated from the full-year company forecast of annual dividends of ¥52.00 and forecast EPS of ¥128.70 is approximately 40.4%, remaining below 60% and indicating that the dividend burden relative to earnings is within a conservative range. The financial foundation of cash and deposits of ¥174.4B and net cash of ¥116.5B provides support for continued dividend payments. No data on share repurchases has been disclosed, and the assessment in this section is based on the payout ratio.

Risk Factors

1. Deteriorating profitability in the largest segment: VCCS generated revenue of ¥415.2B, accounting for approximately 63% of company-wide revenue, while operating income declined △26.1% YoY to ¥15.5B and its operating margin fell from 5.0% to 3.7%. This is the largest risk factor affecting company-wide profitability.

2. Rapid decline in FC・MD earnings: Operating income declined △58.8% YoY to ¥2.7B, and the operating margin fell to 3.2%, with declining profitability weighing on the company's overall margin.

3. Potential recurrence of extraordinary gains and losses: Extraordinary gains and losses resulted in a net loss of ¥5.1B due to ¥9.3B in business structure improvement expenses and ¥1.0B in impairment losses. If additional restructuring expenses or impairment losses arise, they may place further pressure on net income and capital efficiency.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

The company's profitability is below the industry median, likely reflecting the heavy cost structure indicated by the gross margin of 19.4%.

Growth and Capital Efficiency

The revenue growth rate is above the industry median, placing the company's revenue growth trend among the relatively stronger performers in the industry.

※Source: Company analysis

Key Earnings Highlights

1. CTC's operating income increased +113.2% YoY to ¥20.5B, emerging as the core business and accounting for approximately 63% of company-wide operating income. Meanwhile, declines in VCCS and FC・MD lowered the company-wide operating margin by approximately 7bp, with the widening profitability gap between businesses observed as a structural characteristic.

2. Progress against the full-year operating income forecast of ¥45.0B was 72.6%, requiring profitability in Q4 to slightly exceed the cumulative performance to date. How the ¥9.3B in business structure improvement expenses will be reflected in profitability from Q4 onward is a key point of focus.

3. The financial foundation of net cash of ¥116.5B and an equity ratio of 66.5% supports resilience during the business restructuring phase. The structure in which extraordinary losses exceeding extraordinary gains by ¥5.1B pressured net income makes the timing of the shift from front-loaded expenses to earnings improvement an important monitoring point going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,073–¥2,192 at cost of equity ±1%, and ¥2,123–¥2,137 at ω±0.1.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing gap relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was operationally resilient, but below-the-line restructuring and impairment charges caused reported earnings to decline despite higher sales. Revenue increased 6.8% year on year to ¥66.06bn, while operating income rose 5.3% to ¥3.27bn. The operating margin edged down 10bp year on year to 4.9%, as revenue growth was modestly faster than operating-profit growth. Gross profit increased to ¥12.79bn from ¥11.74bn, and the gross margin expanded 40bp to 19.4%. This gross-margin improvement was partly offset by SG&A expense growth of 10.2%, faster than the 6.8% increase in revenue. Ordinary income fell 2.5% to ¥3.62bn because non-operating income declined, notably as foreign-exchange gains fell to ¥0.23bn from ¥0.56bn. Profit attributable to owners of parent decreased 7.6% to ¥2.36bn. Reported net income was further affected by a net extraordinary loss of ¥0.51bn, comprising ¥1.04bn of extraordinary losses against ¥0.53bn of extraordinary income. Restructuring costs of ¥0.93bn and impairment losses of ¥0.10bn were the principal exceptional charges. These were partly offset by a ¥0.31bn gain on negative goodwill associated with the absorption of a network-solution business from KOHWA. CTC was the core business by segment operating-income contribution, generating ¥2.05bn, or approximately 63% of consolidated segment profit. CTC's strong revenue and profit growth offset profit pressure in VCCS and FC・MD. The balance sheet remains highly liquid, with a 221.7% current ratio, ¥17.44bn of cash, and only ¥5.79bn of interest-bearing debt. The principal balance-sheet operating issue is working-capital intensity, as trade receivables rose 22.7% year on year and the reported annualized DSO was 70 days. Full-year guidance remains broadly achievable: Q3 cumulative progress is 74.2% for revenue, 72.6% for operating income, 77.9% for ordinary income, and 78.7% for net income, compared with a standard 75% progress point. The key forward issue is whether CTC profitability can remain strong while VCCS and FC・MD margins recover and restructuring charges subside.

Profitability Analysis

The reported annualized DuPont ROE is 5.7%, decomposed into a 3.6% net profit margin, 1.051x asset turnover, and 1.50x financial leverage. The annualized ROE is below the 8% threshold generally associated with an adequate return profile, with the main constraint being low margin rather than insufficient turnover or excessive leverage. The annualized ROA implied by the net margin and asset turnover is approximately 3.8%, also indicating modest returns on the enlarged asset base. Operating leverage was unfavorable during the period: SG&A increased 10.2% year on year to ¥9.53bn, outpacing the 6.8% increase in revenue, and operating margin consequently declined to 4.9% from approximately 5.0%. The 4.9% EBIT margin triggers the low-operating-efficiency alert because it is below the 5% benchmark; this leaves earnings sensitive to volume, product mix, and fixed-cost changes. The 19.4% gross margin improved 40bp year on year but remains marginally below the 20% alert threshold, indicating limited buffer against procurement, labor, or pricing pressure. CTC was the main earnings driver: revenue rose 25.8% to ¥14.39bn and segment profit surged 113.2% to ¥2.05bn, lifting its margin to 14.2% from 8.4%. VCCS revenue declined 0.7% to ¥41.52bn and segment profit fell 26.1% to ¥1.55bn, compressing margin to 3.7% from 5.0%. FC・MD revenue decreased 0.9% to ¥8.30bn while segment profit fell 58.8% to ¥0.27bn, reducing margin to 3.2% from 7.8%. The newly expanded Incubation Center reported revenue of ¥1.85bn, but its segment loss widened modestly to ¥0.63bn; its margin improved materially to negative 34.2% from negative 282.6% as revenue scaled. The tax burden was normal at 0.758 and the effective tax rate was 23.9%, while the 0.954 interest burden and 24.37x interest coverage demonstrate that financing costs are not constraining profitability. JGAAP accounting is relevant because the company recognizes a ¥0.31bn negative-goodwill gain in extraordinary income from the business succession; this is non-recurring and should not be treated as operating profitability.

Growth Assessment

Revenue growth of 6.8% was supported principally by CTC, where sales rose ¥2.95bn year on year, and by the Incubation Center, where sales increased ¥1.63bn following business expansion. By geography, Japan rose 15.0% to ¥21.67bn, Europe and the Americas grew 4.9% to ¥25.47bn, and Asia increased 1.2% to ¥18.93bn. The regional profile indicates that domestic growth and CTC demand offset weak VCCS and FC・MD sales trends. The mix shift toward CTC was favorable for earnings because its 14.2% segment margin substantially exceeded the consolidated 4.9% operating margin. However, the durability of consolidated growth depends on recovery in VCCS, which remains the largest revenue segment at ¥41.52bn, or 62.9% of consolidated revenue. FC・MD's simultaneous sales and profit decline also warrants monitoring because its margin compression was substantial. Full-year company guidance calls for revenue of ¥89.00bn, operating income of ¥4.50bn, ordinary income of ¥4.65bn, and profit attributable to owners of parent of ¥3.00bn. Q3 progress versus full-year guidance is 74.2% for revenue, 72.6% for operating income, 77.9% for ordinary income, and 78.7% for net income. None of these progress rates deviates by more than 10 percentage points from the standard 75% Q3 run rate. Revenue and operating-income progress modestly below 75% implies a needed Q4 increase, while ordinary-income and net-income progress above 75% should be viewed in light of non-operating and extraordinary items rather than extrapolated mechanically. Guidance implies an operating margin of 5.1%, slightly above the Q3 cumulative 4.9%, requiring modest margin recovery in Q4.

Financial Health

Financial health is solid. Current assets of ¥53.65bn exceeded current liabilities of ¥24.20bn, producing working capital of ¥29.45bn and a strong current ratio of 221.7%. The quick ratio of 184.3% confirms that liquidity does not depend on inventory liquidation. Cash and deposits of ¥17.44bn covered short-term loans of ¥4.19bn by 4.16x. Interest-bearing debt of ¥5.79bn represented approximately 10.4% of total equity, while debt/capital was 9.4%, indicating conservative debt usage. Interest coverage of 24.37x supports a low near-term debt-service risk assessment. The reported D/E ratio of 0.50x remains comfortably below the 2.0x warning threshold. The refinancing-risk alert stems from the 72.4% short-term debt ratio, meaning the debt structure is weighted toward short-term funding. This maturity concentration is a potential refinancing risk in isolation, but its practical impact is mitigated by the large cash balance and strong quick liquidity. Long-term loans decreased ¥1.50bn, or 48.4%, year on year to ¥1.60bn, suggesting deleveraging or migration of borrowings into current maturities. Current liabilities increased 26.7% year on year, faster than current assets growth of 12.8%, though the liquidity cushion remains substantial. Trade payables increased ¥2.00bn, or 32.6%, to ¥8.14bn, partly funding the increase in working capital. Total equity increased 7.1% to ¥55.71bn, assisted by ¥4.82bn of comprehensive income and accumulated foreign-currency translation adjustments of ¥7.48bn. Currency translation adjustments and valuation differences on securities contributed to other comprehensive income; these strengthen reported equity but can be market- and currency-sensitive rather than cash-generative.

Notable B/S Changes

Accounts receivable: +¥3.14bn (+22.7%) to ¥16.98bn - growth substantially exceeded revenue growth, consistent with the reported 70-day annualized DSO and requiring monitoring of collection discipline and operating cash conversion. Inventories: +¥1.26bn (+16.1%) to ¥9.05bn - inventory increased faster than sales, with potential finished-goods demand-timing and obsolescence implications. Accounts payable: +¥2.00bn (+32.6%) to ¥8.14bn - supplier credit expanded and partly funded higher working capital; the sustainability of this funding benefit should be monitored. Long-term loans: -¥1.50bn (-48.4%) to ¥1.60bn - indicates reduced long-term leverage or reclassification toward shorter maturities; the high short-term debt share remains relevant despite strong cash coverage. Total assets: +¥7.55bn (+9.9%) to ¥83.82bn - asset growth was driven primarily by current operating assets and supports the need to monitor working-capital efficiency. Accumulated other comprehensive income: +¥2.45bn (+33.2%) to ¥9.82bn - mainly reflects higher foreign-currency translation and securities valuation balances, increasing equity but also its exposure to market and exchange-rate movements.

Cash Flow Quality

The available financial data do not provide operating cash flow, investing cash flow, financing cash flow, capital expenditure, or free cash flow figures. Cash conversion, OCF-to-net-income coverage, free-cash-flow coverage of dividends, and capex funding capacity are therefore not assessed. Balance-sheet working-capital trends nevertheless require attention: trade receivables rose ¥3.14bn, or 22.7%, year on year to ¥16.98bn, materially faster than revenue growth of 6.8%. The reported annualized DSO of 70 days exceeds the 60-day warning threshold, triggering the high-receivable-days alert. The root cause is slower collection and/or a greater proportion of sales under longer payment terms; either outcome increases the cash tied up in revenue growth. For a manufacturing group, this weakens cash conversion and raises sensitivity to customer credit conditions, even though the ¥17.44bn cash balance currently provides substantial liquidity. Inventories rose ¥1.26bn, or 16.1%, to ¥9.05bn, also faster than sales. Finished goods were ¥9.05bn, raw materials were ¥6.56bn, and work in process was ¥0.51bn; the disclosed inventory categories are not mutually reconcilable to the reported inventory total and are therefore considered separately. Raw materials increased 7.8%, work in process increased 5.2%, and finished goods increased 16.1% year on year. The build in finished goods merits monitoring for demand timing, product-mix changes, and potential inventory obsolescence risk. Payables increased faster than both sales and receivables, rising 32.6% to ¥8.14bn, which partly offsets the cash impact of higher receivables and inventory but may not be a durable source of cash if supplier terms normalize. The absence of reported cash-flow data prevents a determination of whether these working-capital movements are being funded internally or through balance-sheet liquidity.

Dividend Sustainability

The Q2 dividend was ¥25.00 per share. Against Q3 cumulative EPS of ¥101.31, the indicated dividend-only payout ratio is 25.3%, which is conservative. Full-year guidance specifies a ¥52.00 per-share dividend and ¥128.70 EPS, implying a forecast dividend payout ratio of approximately 40.4%. This remains below the 60% sustainability benchmark and leaves a meaningful earnings retention buffer. The balance sheet also supports the planned distribution, with ¥17.44bn of cash, a 221.7% current ratio, and low interest-bearing debt. The dividend outlook is therefore supported by earnings guidance, liquidity, and moderate payout policy. Sustainability should nevertheless be judged against future free cash flow as well as profit, particularly because receivables and inventories increased faster than sales during the period.

Risk Assessment

Business risks include Margin risk is elevated: the 4.9% EBIT margin is below the 5% operating-efficiency threshold, and the 19.4% gross margin is below the 20% threshold. This narrow profitability buffer increases sensitivity to component costs, labor costs, pricing pressure, and sales mix., VCCS, the largest revenue segment, recorded a 0.7% revenue decline and a 26.1% segment-profit decline. A prolonged weakness in this segment would outweigh part of the growth contribution from CTC., FC・MD segment profit declined 58.8% despite only a 0.9% revenue decline, highlighting significant margin sensitivity and possible unfavorable mix or cost absorption., The annualized DSO of 70 days exceeds the 60-day warning threshold. Slower collection or longer customer payment terms can impair cash conversion and increase exposure to customer credit deterioration., Finished goods increased 16.1% year on year, faster than revenue. For an electronics and manufacturing-oriented business, inventory accumulation can create obsolescence, demand-forecast, and product-lifecycle risk., Overseas revenue was ¥44.39bn, or 67.2% of total revenue, exposing results to foreign demand, currency movement, supply-chain conditions, and trade-policy changes. Foreign-exchange gains declined from ¥0.56bn to ¥0.23bn year on year, illustrating volatility in non-operating support..

Financial risks include The 72.4% short-term debt ratio triggers the refinancing-risk alert. The root cause is a debt structure concentrated in short-term loans rather than long-term funding; although cash coverage of 4.16x materially mitigates the immediate risk, funding concentration should be monitored., Receivables rose 22.7% and inventories rose 16.1%, compared with 6.8% revenue growth. This working-capital expansion could reduce operating cash generation if it persists., Reported equity includes ¥9.82bn of accumulated other comprehensive income, including ¥7.48bn of foreign-currency translation adjustments and ¥1.61bn of securities valuation differences. These balances can fluctuate with exchange rates and market prices., Exceptional charges totaled ¥1.04bn, including ¥0.93bn of restructuring costs and ¥0.10bn of impairment. Recurrence would constrain earnings and signal that portfolio optimization has not yet fully concluded..

Key concerns include The highest-priority operating issue is restoring margin in VCCS and FC・MD while sustaining CTC's 14.2% segment margin., The highest-priority cash-conversion issue is the combination of a 70-day annualized DSO and inventory growth above sales growth., The immediate refinancing risk is low because cash substantially exceeds short-term loans, but the high short-term debt share remains relevant under a tighter credit environment., The ¥0.31bn negative-goodwill gain is non-recurring, while restructuring and impairment charges depressed net income; investors should separate these items from sustainable operating earnings..

Investment Implications

Key takeaways include Revenue and operating profit grew 6.8% and 5.3%, respectively, but operating margin declined 10bp to 4.9%., CTC is the core earnings contributor, with ¥14.39bn revenue, ¥2.05bn segment profit, and a 14.2% margin., VCCS and FC・MD experienced material profit pressure, with segment-profit declines of 26.1% and 58.8%, respectively., The financial position is conservative, supported by ¥17.44bn cash, a 221.7% current ratio, 24.37x interest coverage, and 9.4% debt/capital., Working-capital discipline is the key balance-sheet issue: receivables and inventories rose faster than revenue, and annualized DSO reached 70 days., The forecast dividend payout ratio of approximately 40.4% is moderate relative to forecast EPS..

Metrics to watch include VCCS revenue growth and segment margin, FC・MD margin recovery, CTC segment-profit margin sustainability, Consolidated operating margin relative to the 5.1% full-year guidance implication, Annualized DSO and receivables growth relative to sales, Finished-goods inventory growth and inventory valuation risk, Short-term debt ratio and cash coverage of short-term loans, Restructuring and impairment charges after FY2026.

Regarding relative positioning, ヨコオ combines a conservative liquidity and leverage profile with modest consolidated returns. Its annualized 5.7% ROE and 4.9% EBIT margin are below broad profitability benchmarks, but CTC demonstrates a high-margin growth engine. Relative performance will depend on converting this CTC strength into sustained consolidated margin expansion while containing working-capital intensity and stabilizing the larger VCCS business.